title: The IL-23/Th 17 pathway in spondyloarthritis: the royal road?
authors.affiliation: Service de rhumatologie, CHRU de Besançon, université de Franche-Comté, boulevard Fleming, 25030 Besançon, France. Electronic address: dwendling@chu-besancon.fr.
authors.forename: Daniel
authors.initials: D
authors.lastname: Wendling
authors.affiliation: Service de rhumatologie, CHRU de Besançon, université de Franche-Comté, boulevard Fleming, 25030 Besançon, France.
authors.forename: Xavier
authors.initials: X
authors.lastname: Guillot
authors.affiliation: Service de rhumatologie, CHRU de Besançon, université de Franche-Comté, boulevard Fleming, 25030 Besançon, France.
authors.forename: Clément
authors.initials: C
authors.lastname: Prati
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D006801:Humans; D020381:Interleukin-17 / Q000096:biosynthesis / Q000276:immunology*; D053759:Interleukin-23 / Q000276:immunology*; D020641:Polymorphism, Single Nucleotide; D025241:Spondylarthritis / Q000097:blood / Q000188:drug therapy / Q000235:genetics / Q000276:immunology*; D058504:Th17 Cells / Q000276:immunology*
chemical_list: D000911:Antibodies, Monoclonal; D020381:Interleukin-17; D053759:Interleukin-23
keywords: Interleukin-17; Interleukin-23; Pathophysiology; Spondyloarthritis; Treatment